UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2911) 2911
Book Chapter (77) 77
Dissertation (14) 14
Magazine Article (5) 5
Book / eBook (3) 3
Publication (3) 3
Conference Proceeding (1) 1
Government Document (1) 1
Newspaper Article (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (2280) 2280
life sciences & biomedicine (2165) 2165
humans (1397) 1397
oncology (1058) 1058
mek (990) 990
animals (895) 895
mek inhibitors (786) 786
melanoma (640) 640
mutation (559) 559
cell biology (557) 557
signal transduction (532) 532
kinases (499) 499
cancer (489) 489
cell line, tumor (487) 487
biochemistry & molecular biology (480) 480
mice (453) 453
apoptosis (430) 430
mek inhibitor (429) 429
tumors (423) 423
extracellular signal-regulated kinase (421) 421
female (414) 414
phosphorylation (407) 407
map kinase (366) 366
proteins (363) 363
protein kinase inhibitors - pharmacology (353) 353
male (344) 344
erk (314) 314
pharmacology & pharmacy (292) 292
map kinase signaling system - drug effects (280) 280
braf (277) 277
biological and medical sciences (275) 275
signal transduction - drug effects (273) 273
metastasis (269) 269
inhibitors (267) 267
enzyme inhibitors - pharmacology (253) 253
mitogen-activated protein kinase kinases - antagonists & inhibitors (234) 234
gene expression (232) 232
research (232) 232
cell proliferation (228) 228
melanoma - drug therapy (227) 227
antineoplastic agents - pharmacology (225) 225
extracellular signal-regulated map kinases - metabolism (221) 221
apoptosis - drug effects (215) 215
mitogen-activated protein kinase kinases - metabolism (211) 211
medical sciences (208) 208
metastases (206) 206
analysis (205) 205
rats (204) 204
proto-oncogene proteins b-raf - genetics (203) 203
care and treatment (202) 202
patients (200) 200
mitogen-activated protein kinases - metabolism (198) 198
protein kinase inhibitors - therapeutic use (196) 196
immunotherapy (188) 188
cell proliferation - drug effects (187) 187
chemotherapy (180) 180
antineoplastic agents - therapeutic use (179) 179
cancer therapies (172) 172
genetic aspects (171) 171
middle aged (169) 169
cells, cultured (167) 167
mapk (164) 164
trametinib (163) 163
map kinase signaling system (161) 161
targeted therapy (160) 160
ras (159) 159
neoplasms (154) 154
antineoplastic agents (153) 153
proto-oncogene proteins b-raf - antagonists & inhibitors (152) 152
research article (152) 152
aged (151) 151
phosphatidylinositol 3-kinases - metabolism (151) 151
map kinase kinase kinases - antagonists & inhibitors (149) 149
clinical trials (148) 148
cell cycle (146) 146
drug resistance (144) 144
health aspects (142) 142
protein kinases (142) 142
melanoma - genetics (141) 141
cell growth (140) 140
biophysics (139) 139
mek/erk (139) 139
melanoma - pathology (137) 137
cell line (135) 135
lung cancer (135) 135
adult (132) 132
signaling (132) 132
dose-response relationship, drug (129) 129
map kinase kinase 1 - antagonists & inhibitors (129) 129
raf (129) 129
neurosciences & neurology (128) 128
nitriles - pharmacology (128) 128
xenograft model antitumor assays (128) 128
protein kinase (127) 127
butadienes - pharmacology (126) 126
blotting, western (124) 124
flavonoids - pharmacology (124) 124
pi3k (124) 124
drug therapy (123) 123
neurosciences (122) 122
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2955) 2955
Chinese (31) 31
German (17) 17
Japanese (12) 12
French (9) 9
Korean (6) 6
Russian (3) 3
Czech (2) 2
Norwegian (2) 2
Spanish (2) 2
Polish (1) 1
Portuguese (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International journal of cancer, ISSN 0020-7136, 11/2013, Volume 133, Issue 9, pp. 2089 - 2101
lung cancer | colorectal cancer | combination of molecular targeted therapies | MEK inhibitors | Life Sciences & Biomedicine | Oncology | Science & Technology | Chemotherapy | Pharmacology. Drug treatments | Biological and medical sciences | Medical sciences | Animal tumors. Experimental tumors | Experimental tumors, general aspects | Antineoplastic agents | Tumors | Lung Neoplasms - drug therapy | Oligonucleotide Array Sequence Analysis | TOR Serine-Threonine Kinases - metabolism | Apoptosis - drug effects | Phosphatidylinositol 3-Kinase - antagonists & inhibitors | Humans | Lung Neoplasms - metabolism | Lung Neoplasms - pathology | Gene Expression Profiling | TOR Serine-Threonine Kinases - antagonists & inhibitors | Colorectal Neoplasms - drug therapy | Biomarkers, Tumor - metabolism | Female | Tumor Cells, Cultured | Proto-Oncogene Proteins c-akt - metabolism | Phosphatidylinositol 3-Kinase - metabolism | Colorectal Neoplasms - metabolism | MAP Kinase Kinase 1 - antagonists & inhibitors | PTEN Phosphohydrolase - metabolism | MAP Kinase Kinase 1 - metabolism | MAP Kinase Kinase 2 - metabolism | Blotting, Western | Xenograft Model Antitumor Assays | Animals | Signal Transduction - drug effects | MAP Kinase Kinase 2 - antagonists & inhibitors | Biomarkers, Tumor - genetics | Cell Proliferation - drug effects | Mice | Mice, Inbred BALB C | Phenylurea Compounds - pharmacology | Protein Kinase Inhibitors - pharmacology | Pyridines - pharmacology | Cell Cycle - drug effects | Colorectal Neoplasms - pathology | Proto-Oncogene Proteins c-akt - antagonists & inhibitors | Drug Resistance, Neoplasm - drug effects | Colorectal cancer | Pharmacology | Kinases | Lung cancer | Index Medicus | Medicin och hälsovetenskap
Journal Article
International journal of cancer, ISSN 0020-7136, 05/2018, Volume 142, Issue 10, pp. 2139 - 2152
Journal Article
Leukemia, ISSN 0887-6924, 07/2011, Volume 25, Issue 7, pp. 1159 - 1167
BMS-214662 | HSC | MEK inhibitor | CML | TKI | PD184352 | Oncology | Life Sciences & Biomedicine | Hematology | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Antigens, CD34 - analysis | Apoptosis - drug effects | Neoplastic Stem Cells - drug effects | Humans | Leukemia, Myeloid, Chronic-Phase - pathology | Neoplasm Proteins - antagonists & inhibitors | K562 Cells - drug effects | Blast Crisis - enzymology | MAP Kinase Kinase 1 - genetics | Tumor Cells, Cultured - enzymology | Genes, Dominant | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - pathology | Benzamides - pharmacology | Farnesyltranstransferase - antagonists & inhibitors | MAP Kinase Kinase Kinases - antagonists & inhibitors | Hematopoietic Stem Cells - drug effects | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - enzymology | Benzodiazepines - pharmacology | Blast Crisis - pathology | Tumor Cells, Cultured - drug effects | Enzyme Inhibitors - pharmacology | Imidazoles - pharmacology | Leukemia, Myeloid, Chronic-Phase - enzymology | K562 Cells - enzymology | Drug Synergism | Recombinant Fusion Proteins - genetics | Genes, ras | Hematopoietic Stem Cells - enzymology | Neoplastic Stem Cells - enzymology | Drug Screening Assays, Antitumor | Oncogene Protein p21(ras) - genetics | Antimitotic agents | Physiological aspects | Chronic myeloid leukemia | Research | Drug therapy | Antineoplastic agents | Protein kinases | Health aspects | Apoptosis | Index Medicus | FTI | CD34
Journal Article
European journal of cancer (1990), ISSN 0959-8049, 2013, Volume 50, Issue 2, pp. 406 - 410
Journal Article